Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583868 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT01583868 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 216 participants.
The verdict
NCT01583868, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2) developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb PureVision®2 HD (high definition) soft contact lenses and Ciba Vision Air Optix Aqua soft contact lenses when used among currently adapted soft contact lens wearers.
Interventions
- DEVICE Air Optix Aqua
- DEVICE B&L RD2135-01 lens C
- DEVICE B&L RD2135-01 lens D
- DEVICE PureVision2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01583868
The ClinicalTrials.gov registry entry for NCT01583868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Air Optix Aqua is the first listed.
NCT01583868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01583868 about?
NCT01583868 is a clinical study titled "A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses". The objective of this study is to determine the clinical feasibility and to evaluate the product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2) developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb PureVision®2 HD (high definition) s...
What is the current status of trial NCT01583868?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2012-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01583868?
The interventions under investigation include: Air Optix Aqua (DEVICE), B&L RD2135-01 lens C (DEVICE), B&L RD2135-01 lens D (DEVICE), PureVision2 (DEVICE).
Who is sponsoring clinical trial NCT01583868?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.